ELYSIUM HEALTH, INC.
EH302, an oral small-molecule therapeutic that elevates NAD+ levels and activates sirtuins (Sirt1/3) to modify osteoarthritis progression
- Sector
- Biotech
- Headquarters
- NEW YORK, NY
- Founded
- 2015
- Latest Form D
- $20M, Dec 2016
- Total capital
- $20.3M
- Federal grants
- $283K
- 1 award · 2023
- Rank in peer group#120 of 392
- Private capital raised
- $20M
- 1 Form D · last Dec 2016
- 119 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 12
- 28 pending · first 2021
- Rank in peer group#9 of 392
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Development of Nicotinamide-Riboside plus Pterostilbene as a Disease Modifying Osteoarthritis Therapeutic$283K
- Private capital raisedForm D · SEC · 1st filing$20M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 392 peers
Line = medianBiotech · Molecule
- Federal grants#120 · top 31%
- Granted patents#9 · top 2%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Eric MarcotulliResearcherExecutive Officer, Director, PromoterLinked by 5 patents
- Daniel AlminanaExecutive Officer, Director, PromoterNamed in SEC Form D filings
- David P. FialkowDirectorNamed in SEC Form D filings
- Jim P. ManziDirectorNamed in SEC Form D filings
What it has protected
USPTO · 12 granted of 40- GrantedMethods And Compositions For Treating Motor Neuron DiseasesUSPTOUS 12,350,283
- GrantedNicotinamide Riboside For Use In Treating Or Preventing Liver DamageUSPTOUS 12,128,060
- GrantedNicotinamide Riboside And Pterostilbene Compositions And Methods For Treatment Of Skin DisordersUSPTOUS 12,109,206
Show all 40 patent records
- Methods And Compositions For Treating Motor Neuron DiseasesJul 8, 2025 · US 12,350,283Granted
- Nicotinamide Riboside For Use In Treating Or Preventing Liver DamageOct 29, 2024 · US 12,128,060Granted
- Nicotinamide Riboside And Pterostilbene Compositions And Methods For Treatment Of Skin DisordersOct 8, 2024 · US 12,109,206Granted
- Crystalline Forms Of Nicotinamide Riboside ChlorideJul 23, 2024 · US 12,043,616Granted
- Nicotinamide Riboside And Pterostilbene Compositions And Methods For Treatment Of Neurodegenerative DisordersJun 4, 2024 · US 11,998,561Granted
- Methods Of Synthesizing Nicotinamide RibosideNov 2, 2023 · Application 18131058Pending
- Treating And Preventing Motor Neuron Diseases Using Nicotinamide RibosideAug 22, 2023 · US 11,730,751Granted
- Methods Of Synthesizing Nicotinamide RibosideApr 18, 2023 · US 11,629,163Granted
- Nicotinamide Riboside And Pterostilbene Compositions And Methods For Treatment Of Skin DisordersAug 30, 2022 · US 11,426,398Granted
- Crystalline Forms Of Nicotinamide Riboside ChlorideAug 16, 2022 · US 11,414,407Granted
- Nicotinamide Riboside For Use In Treating Or Preventing Liver DamageJul 19, 2022 · US 11,389,468Granted
- Nicotinamide Riboside And Pterostilbene Compositions And Methods For Treatment Of Neurodegenerative DisordersMar 1, 2022 · US 11,260,069Granted
- Treating And Preventing Kidney DamageSep 28, 2021 · US 11,129,843Granted
- Methods And Compositions For Treating Multiple SclerosisJun 24, 2021 · Application 16768299Pending
- Methods And Compositions For Treating Childhood Or Teen ObesityJun 17, 2021 · Application 16768272Pending
- Methods And Compositions For Treating GlaucomaDec 10, 2020 · Application 16768267Pending
- Methods And Compositions For Treating Premature Aging DiseasesOct 22, 2020 · Application 16754072Pending
- Prevention And Treatment Of TDP-43 Associated DiseasesOct 22, 2020 · Application 16757037Pending
- Methods And Compositions For Treating Cystic FibrosisAug 20, 2020 · Application 16760317Pending
- Methods And Compositions For Improving SleepMar 19, 2020 · Application 16614249Pending
- Methods Of Synthesizing Nicotinamide RibosideApplication PCTUS2018040228Pending
- Methods And Compositions For Improving SleepApplication PCTUS2018033406Pending
- Methods And Compositions Of Improving FertilityApplication PCTUS2018028809Pending
- Treating And Preventing Kidney DamageApplication PCTUS2018028807Pending
- Treating And Preventing Liver DamageApplication PCTUS2018022854Pending
- Treating And Preventing Motor Neuron Diseases Using Nicotinamide RibosideApplication 62614003Pending
- Methods and Compositions for Treating Cystic FibrosisApplication 62578559Pending
- Nicotinamide Riboside And Pterostilbene Compositions And Methods For Treatment Of Neurodegenerative DisordersApplication PCTUS2017047979Pending
- Treating and Preventing Motor Neuron Diseases Using Nicotinamide RibosideApplication 62507585Pending
- Nicotinamide Riboside And Pterostilbene Compositions And Methods For Treatment Of Skin DisordersApplication PCTUS2016019653Pending
- Compositions And Methods Of Treating RosaceaApplication 62173733Pending
- Deacylation Of Carbohydrate CompoundsApplication PCTUS2023064099Pending
- Ribose Linkers And Conjugates ThereofApplication PCTUS2023061917Pending
- Methods For Treatment Of Menopausal SyndromesApplication PCTUS2022077944Pending
- Methods For Treatment Of Viral InfectionsApplication PCTUS2021023464Pending
- Methods For Treatment Of Viral InfectionsApplication 63004958Pending
- Methods For Wound TreatmentApplication PCTUS2020022596Pending
- Methods And Compositions For Treating Motor Neuron DiseasesApplication PCTUS2020019600Pending
- Methods For Determining And Increasing Nad LevelsApplication PCTUS2019061146Pending
- Methods And Compositions For Treating Motor Neuron DiseasesApplication 62892754Pending
Related companies, and why
- Poplar TherapeuticsSimilar federal contract value in Biotech · null in contracts
- BLOOD CELL TECHNOLOGIES LLCSimilar federal contract value in Biotech · null in contracts
- OSEL, INC.Similar federal contract value in Biotech · null in contracts
- Moerae Matrix, Inc.Similar federal contract value in Biotech · null in contracts
- Rondo TherapeuticsSimilar federal contract value in Biotech · null in contracts
- GROW BIOMEDICINE LLCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .